LINDSAY HINDSMAN: Open Payments
NPI 1871368928 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 40 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,348 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $426 |
| Janssen Biotech, Inc. | 7 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Ardelyx, Inc. | 3 | $65 |
| PFIZER INC. | 3 | $60 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, CREON, IBSRELA, VELSIPITY, RINVOQ, LINZESS.
Industry payments across FL — which companies pay providers there.
